Page 21 - Drugs Controller News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WASHINGTON: As India experiences a new wave of Covid-19 pandemic, an Indian public healthcare expert has called for adopting a “build, buy and jab” strategy for mass vaccination to handle the crisis along with the enforcement of appropriate behaviours and continuous communication from doctors, political leaders and administration. “We are witnessing an awful resurgence of the pandemic in India, where it was perceived, just a few months back, to be essentially over. Unfortunately, it lurked in the population and hit back with a vengeance when our guard was down,” Indian civil servant ...

More data is needed to establish if a third anti-COVID-19 booster dose will more effectively help in fighting the surge in infections in the country as currently its requirement has been based more upon conjecture, health experts said. India is battling a massive surge in COVID-19 cases and health ministry data updated on Sunday showed that a record single-day rise of 2,61,500 coronavirus infections has taken the country's total tally to 1,47,88,109, while active cases have surpassed the 18-lakh mark. Pfizer and Moderna recently announced that people who have received both doses of the Pfi...

The development comes after DCGI (Drugs Controller General of India) gave its nod to foreign-made and approved COVID-19 vaccines following a massive spike in coronavirus cases

Sensex closed over 600 points higher today recovering partial losses from the market crash yesterday. A rally in the beaten down financial stocks and rise in metal share due to jump in commodity prices led to the rebound in trade today.

India News: The Covid-19 task force on Tuesday recommended the government to authorise those foreign-produced Covid-19 vaccines which have been granted emergency